Life cycle and molecular virology.- Unmet needs in basic research: in vitro and in vivo models.- Immunopathogenesis.- Epidemiology and natural history.- Hepatitis B vaccination.- Viral factors and disease progression.- Host genetic factors and disease progression.- Molecular carcinogenesis of HCC.- Interferon therapy and long-term outcomes.- Nucleotide therapy and long-term outcomes.- Combination therapy.- Treatment of patients with HCV, HDV or HIV co-infection.- Management of children and pregnant women.- Management of patients with immunosuppressive therapy.- Towards an HBV cure: discovery of novel agents.- Others: occult HBV infection.
Editor Jia-Horng Kao is a Professor at the Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Professor Ding-Shinn Chen is a Professor at the Genomics Research Center, and the Academician of Academic Sinica, Taipei, Taiwan.
"The purpose is to present updated information regarding the pathogenesis, epidemiology, and prevention of hepatitis B, with a strong emphasis on basic and translational medicine. The audience includes students, healthcare providers, and researchers interested in hepatitis B or who wish to stay up to date in this area. The book would be of the greatest benefit to research-oriented readers and/or those working in geographic areas highly endemic in hepatitis B." (Cezarina Mindru, Doody's Book Reviews, April, 2018)